Drug application
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE)
Drugs@FDA ANDA 202001 · TORRENT PHARMS LTD
Key facts
| Drug name | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE |
|---|---|
| Active ingredients | METFORMIN HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 202001 |
| Company | TORRENT PHARMS LTD |
| Dosage forms | TABLET, ORAL |
| Strength | 500MG;EQ 15MG BASE |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission class | Not Applicable |
| Latest submission status date | Feb 13, 2013 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.